Guo Xiang Cheng
Algemeen Directeur bij Shanghai Genon Biological Product Co., Ltd.
Profiel
Guo Xiang Cheng is currently the Chairman & General Manager at Shanghai Genon Biological Product Co., Ltd., Chairman at Shanghai Rui Dong Hospital, Chairman at Shanghai Transgenic Research Center, and President-Biotechnology at Tongji University.
He holds a doctorate degree from Shanghai Jiao Tong University, conferred in 1998, and an undergraduate degree from Yangzhou University, conferred in 1985.
Actieve functies van Guo Xiang Cheng
| Bedrijven | Functie | Begin |
|---|---|---|
Shanghai Genon Biological Product Co., Ltd.
 Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Algemeen Directeur | - |
| Shanghai Rui Dong Hospital | Voorzitter | 10-03-2010 |
| Shanghai Transgenic Research Center | Voorzitter | 10-03-2010 |
| Tongji University | Corporate Officer/Principal | 10-03-2010 |
Opleiding van Guo Xiang Cheng
| Yangzhou University | Undergraduate Degree |
| Shanghai Jiao Tong University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Shanghai Genon Biological Product Co., Ltd.
Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Rui Dong Hospital | |
| Shanghai Transgenic Research Center |